Pharmacy - Drug Approvals News & Articles

1 FDA has updated flush list for disposing of medications safely Full Text American Pharmacists Association News, May 22, 2013

2 Site of Care May Impact Breast Cancer Management and Economic Outcomes Full Text First Report Managed Care, May 20, 2013

3 FDA Drug Safety Communication: FDA approves label changes for zolpidem products, including new dosing and a recommendation to avoid driving the day after Ambien CR use Full Text FDA What's New: Drugs, May 17, 2013

4 Rotavirus vaccine developed in India shows positive results Full Text American Pharmacists Association News, May 17, 2013

5 FDA approves Nymalize--first nimodipine oral solution for use in certain brain hemorrhage patients Full Text FDA Press Announcements, May 17, 2013

6 FDA approves first companion diagnostic to detect gene mutation associated with a type of lung cancer Full Text FDA Press Announcements, May 17, 2013

7 FDA approves new drug for advanced prostate cancer Full Text FDA Press Announcements, May 17, 2013

8 FDA approves Tarceva (erlotinib) tablets and cobas EGFR Mutation Test for specific type of lung cancer Full Text Roche, May 16, 2013

9 Ranibizumab: The First Vascular Endothelial Growth Factor Inhibitor Approved for the Treatment of Diabetic Macular Edema Annals of Pharmacotherapy, May 13, 2013    Review Article

10 Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US for Maintenance Treatment in Children and Adolescents with ADHD Full Text Shire, May 10, 2013

11 FDA Approves Mercks LIPTRUZET (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol Full Text Merck, May 8, 2013

12 Adherence Associated with Oral Medications in the Treatment of Spasticity PM&R, May 8, 2013    Clinical Article

13 Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar(R) / Prolopa(R) Full Text BMC Pharmacology & Toxicology, May 7, 2013    Clinical Article

14 Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA Perspective Clinical Pharmacology & Therapeutics, May 6, 2013    Clinical Article

15 New treatment options for castration-resistant prostate cancer American Journal of Health-System Pharmacy, May 3, 2013    Clinical Article

16 Rivoglitazone: A New Thiazolidinedione for the Treatment of Type 2 Diabetes Mellitus Annals of Pharmacotherapy, May 2, 2013    Clinical Article

17 Canagliflozin: First in class for type 2 diabetes Full Text American Pharmacists Association News, May 2, 2013

18 Dimethyl fumarate: Oral option for MS Full Text American Pharmacists Association News, May 2, 2013

19 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Full Text Merck, April 29, 2013

20 Mycophenolate Fetal Toxicity and Risk Evaluation and Mitigation Strategies American Journal of Transplantation, April 29, 2013    Review Article

1 Phentermine and topiramate for the management of obesity: a review Drug Design, Development and Therapy, April 12, 2013    Free full text    Review Article

2 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

3 FDA approves three new drug treatments for type 2 diabetes FDA Press Announcements, January 29, 2013    Free full text

4 Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 2, 2013

5 Unapproved Drugs--The Drug Information Pharmacists Perspective Journal of Pharmacy Practice, March 29, 2013    Review Article

6 Ceftaroline - a cause for neutropenia Journal of Clinical Pharmacy and Therapeutics, April 22, 2013

7 Novartis receives EU approval for Ilaris in patients suffering acute gouty arthritis attacks who cannot gain relief from current treatments Novartis, March 4, 2013    Free full text

8 FDA approves new multiple sclerosis treatment: Tecfidera FDA Press Announcements, April 1, 2013    Free full text

9 Benefits and Risks of Daily Aspirin Use U.S. Pharmacist, February 27, 2013    Free full text

10 Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation Chugai Pharmaceutical Co., March 26, 2013    Free full text

11 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck, April 29, 2013    Free full text

12 Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes Sarepta Therapeutics, April 19, 2013    Free full text

13 FDA Advisory Committee Recommends Approval for Boehringer Ingelheims Olodaterol* for Maintenance Treatment of COPD Boehringer Ingelheim, January 31, 2013    Free full text

14 FDA Lists Guidance Documents Planned for 2013 BioPharm International, February 11, 2013    Free full text

15 Apixaban: Third oral anticoagulant to compete with warfarin American Pharmacists Association News, March 14, 2013    Free full text

16 Pomalidomide: Thalidomide analogue for multiple myeloma American Pharmacists Association News, April 5, 2013    Free full text

17 FDA approves abuse-deterrent labeling for reformulated OxyContin FDA Press Announcements, April 18, 2013    Free full text

18 FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes FDA Press Announcements, March 25, 2013    Free full text

19 Quality-improvement analytics for intravenous infusion pumps American Journal of Health-System Pharmacy, April 11, 2013

20 Targeting kinases: a new approach to treating inflammatory rheumatic diseases Current Opinion in Pharmacology , March 22, 2013    Review Article